pamidronate
Selected indexed studies
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. (J Clin Oncol, 2001) [PMID:11208851]
- Pamidronate. (Ann Pharmacother, 1992) [PMID:1421653]
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. (J Oral Maxillofac Surg, 2003) [PMID:12966493]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. (2001) pubmed
- Pamidronate. (1992) pubmed
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. (2003) pubmed
- Pamidronate (Aredia, Ciba). (1998) pubmed
- Pamidronate: A model compound of the pharmacology of nitrogen-containing bisphosphonates; A Leiden historical perspective. (2020) pubmed
- Pamidronate lines. (2005) pubmed
- Pamidronate treatment in rheumatology practice: a comprehensive review. (2009) pubmed
- Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone. (1998) pubmed
- Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. (1991) pubmed
- Pamidronate. (1992) pubmed